KCTD7 Polyclonal Antibody
| Code | Size | Price |
|---|
| E-AB-52089-20uL | 20uL | £125.00 |
Quantity:
| E-AB-52089-60uL | 60uL | £172.00 |
Quantity:
| E-AB-52089-120uL | 120uL | £237.00 |
Quantity:
| E-AB-52089-200uL | 200uL | £344.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
- Human
- Mouse
- Rat
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Western Blot (WB)
Shipping:
Ice packs
Storage:
Store at -20°C. Avoid freeze / thaw cycles.
Further Information
Abbreviation:
KCTD7
Background:
KCTD7 (Potassium Channel Tetramerization Domain Containing 7) is a Protein Coding gene. Diseases associated with KCTD7 include Epilepsy, Progressive Myoclonic 3, With Or Without Intracellular Inclusions and Cln14 Disease. Among its related pathways are Neuropathic Pain-Signaling in Dorsal Horn Neurons and Innate Immune System. An important paralog of this gene is KCTD14. This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.
Buffer:
PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
Calculated MW:
33 kDa
Concentration:
1.26 mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:500-1:2000, ELISA 1:5000-1:10000
Immunogen:
Synthetic peptide of human KCTD7
ObservedMW:
Refer to figures
Purification method:
Antigen affinity purification
Target Synonym:
BTB/POZ domain containing protein KCTD7;EPM3;FLJ32069;Potassium channel tetramerisation domain containing 7
UNIProt ID:
Q96MP8